Helping people in need !!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
ATHX volume is the highest in weeks and I would not be surprised if we see a BARDA Collaboration/Funding tweet soon followed by Athx tweet:
Regarding, Diane Moore Multistem ARDS Testimonial you can check her out which this woman is very passionate about her experience and openly shares it on her Facebook page. Also the American Academy of Stem Cell Physicians is Hosting an FDA Safety Panel. Aug. 1-3, 2020. This is a highly anticipated session. The Safety panel discussion will discuss advancements in development, manufacturing and delivery of safe and effective regenerative cell therapies.
Diane Moore Mohrman
Multistem ARDS Patient Testimonial
Here is a testimonial from a patient in Cleveland who had ARDS, and received Multistem and it saved her life: ———————-
I know many of you know my story but some do not...but it’s my daily reality... 2 years ago, in early 2018 I was fighting for my life. My family was with me the whole time. I was in the MICU at Elyria hospital for a week with pneumonia. I was told by my nurse, Darla early on a Wednesday morning I had to be transferred to UH Cleveland. I flatly said no. She said if I wanted to live I had to go. An hour later, on I was on life support, in a medical induced coma & that night transferred to UH Cleveland. I was in the ICU on a ventilator for 14 days. I was in a coma 10 days. On Friday, doctors brought in an end of life nurse for my family. I was not expected to live. Saturday, (now this is what I’ve been told) an ‘angel’ walked into a meeting with my family. She talked to them about a muiltstem therapy for ARDS trial. I was a good candidate for the trial because...I had pneumonia I was sepsis, my organs were starting to shut down. My lungs were filling with fluid. I had 3 different IV poles filled with medicine going into my veins. The trial was bone marrow taken from younger person. A blind study, meaning no one in study, doctors or patients knew if it was bone marrow or placebo in a IV. That happened Sunday. Again, I was in a coma had no clue. By Friday I was waking up. Saturday I remember my brothers being with me. Still not able to communicate being on a ventilator. Very weak, could not even tap on my brother, David’s phone. And I could not write. Not being able to communicate...I used my eyes to follow nurses coming in & out of my room. I remember holding my brother, Denny’s hand. His strength going into me. ?By Tuesday, 14 days later the tube came out. With the real possibility of me having a tracheotomy?. I was told to breath in/out & cough hard. My respiratory therapist worked with me. My stats stayed up. I don’t know numbers but it was good enough. I had a tube up nose for what I don’t remember. Following days later a swallow tests...finally some soft food. I was moved to a regular room. Had a lot still going on but I’m alive. I can chew, drink & talk a little. I was transferred to UH Avon rehab. There for 10 days. I very grateful for those therapists. They got me moving. 40 some days later I was home. I had ARDS which is Acute Respiratory Distress Syndrome. My lungs are now scarred from this illness. I use oxygen still. I have heart/kidney problems from it. But, I can breathe on my own! That was my reality...still is & my family’s. Covid-19 is a respiratory illness. If I caught this virus I may not live. I have folks in my fb friends that are down playing this virus. You know what my reality is daily? I’m on 12 different meds, I go to doctor appointments for my heart & kidneys & I’m admitted to the hospital a few times a year. Yes it’s still my reality. I lost my job I’m on disability & now I’m on Medicare. I’m only 54 years old, but it is My reality. Don’t play around be a responsibility adult because my life depends on it. If you are sick stay home. Wash your hands...stop fighting wearing a face mask in public?—you all know the drill. Yes it’s hot yes sometimes it’s hard to breathe but it’s ALL OUR REALITY! My retailer friends...thank you! I love you all & I love my brother. You all are working many long hard hours to keep the shelves stocked. Please go easy on those working in the retail business. They HAVE to be masked for their safety & your safety. The medical staff—-YOU GUYS ROCK!!! You are on the front line doing what you do best. You work long hours, never complain (not that we see??) thank you! Folks in Lorain County in my home town Elyria we are in this together. Let’s come together & shine. You all know what to do it’s been all over the news & social media. Thank you & my love to each of you... **This past February before Covid 19 started I received an email from my ‘angel’ Mary. She said...as we all knew I was a recipient of the bone marrow in an IV given to me 2 years earlier that saved my life. I was 1 of the first to be in the blind study. Today that study is now for covid 19.
This woman is very passionate about her experience and openly shares it on her Facebook page.
How is it possible Multistem hasn’t been funded? Where is the urgency?
It’s sad that politicians are playing with people’s lives. 150,000 Covid 19 patients have died in USA, please God have mercy and put some sensibility in to these politicians! Athersys SHOULD be the biotech of the century !!!!!!!!!!
Healios today announces that the first COVID-19 Induced ARDS patient has been enrolled in its ONE-BRIDGE clinical trial testing the safety and efficacy of adult stem cell regenerative medicine HLCM051 in patients with pneumonia-induced ARDS in Japan!
Also Hong Kong's Lam says the territory is on the verge of a major outbreak and the medical system is close to collapse. The U.S.cases surpass 4M and deaths top 150K.
T2 lies in a very wide and strong rising trend short term, this normally pose a very good buying opportunity. If the lower trendfloor at $1.52 is broken, it will firstly indicate a slower rising rate, but may also be a early warning for a trend shift. T2 should rise over 130% in the next 2-3 months and a 90% hold a price between $3.50-$6.00 at the end of this period .. GOOD LUCK LONGS
In the latest trading session, T2 Biosystems (TTOO) closed at $1.62, marking a +0.62% move from the previous day. This change outpaced the S&P 500's 0.62% loss on the day. At the same time, the Dow lost 0.69%, and the tech-heavy Nasdaq lost 0.94%.
Prior to today's trading, shares of the diagnostics company had gained 19.26% over the past month. This has outpaced the Medical sector's gain of 2.18% and the S&P 500's gain of 3.51% in that time.
Investors will be hoping for strength from TTOO as it approaches its next earnings release. On that day, TTOO is projected to report earnings of -$0.18 per share, which would represent year-over-year growth of 48.57%.
Any recent changes to analyst estimates for TTOO should also be noted by investors. Recent revisions tend to reflect the latest near-term business trends. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. The Zacks Consensus EPS estimate remained stagnant within the past month. TTOO is currently sporting a Zacks Rank of #3 (Hold).
The Medical - Instruments industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 160, which puts it in the bottom 38% of all 250+ industries.
The Zacks Industry Rank includes is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
There's a thoughtful and insightful discussion happening right now on the $ATHX Reddit board entitled "FOCUS: Mesoblast Scalability Issue". A must read for all $MESO investors.
https://www.reddit.com/r/ATHX/comments/hx3k8c/focus_mesoblast_scalability_issue/?utm_source=share&utm_medium=web2x
Here's a little taste:
"While each MSC product is completely different, other than useful observations, currently accessible data are insufficient to conclusively determine how tissue source, isolation method, and culture/scale-up during MSC product development can affect the therapeutic efficacy of MSCs. To highlight this point, we consider the phase 3 trial using remestemcel-L conducted for both adult and pediatric GvHD populations that was unable to meet primary clinical end points in a mixed-age patient population, despite demonstrating a positive impact on the liver and gut in earlier stages of the study. All remestemcel-L MSCs used in the phase 3 trial were derived from a single donor, requiring cells to be expanded to passages 3 and 4 during manufacturing to yield enough MSCs to treat all 240 participants. Conversely, a separate phase 2 trial on therapeutic MSCs conducted by the University Hospital Frankfurt avoided this failure for the same clinical indication in a similar patient population. In this study, pooled MSCs were used to treat 26 patients with GvHD using passage 1 and 2 MSCs from eight donors to yield sufficient quantities of MSCs. Results from this study demonstrated improved clinical efficacy in GvHD patients at the primary end point (day 28), with an overall response rate of 77%. While this comparison appears to illustrate the importance of MSC sourcing and manufacturing at the commercial scale, differences highlighted here as well as subtle differences in the preparation of the MSC product make it challenging to draw conclusions."
New Freight Waves article with broker comments RE: what’s causing Capesize dry bulk shipping rates to tumble + when downward trend may reverse + latest index data from Baltic and Platts: $SBLK $SHIP $SALT $GOGL $GNK $EGLE #BDRY $BDI $VALE
https://www.freightwaves.com/news/dry-bulk-shipping-rates-slashed-in-half
Another GOOD article on TTOO ..
https://financemarkethouse.com/2020/07/23/ttoo-t2-biosystems-super-deep-backgrounder-on-future-catalysts-science/
Daily average earnings for capesizes, which typically transport cargoes of 170,000 tonnes to 180,000 tonnes, including iron ore and coal. I don't follow Tate Sullivan but respect the HOLD Rating .. I'm hanging on with this one, with hopes of great recovery when the virus is stomped out and the global economy ramps up to normal levels. I'm already down and have increased my position. I watched interview and how interesting to see how long it takes for people to get their finances in order to take advantage of this incredible price. The outlook for SHIP is excellent. This stock will fly it's a matter of time and SHOULD BE A BIG WINNER .. GOOD LUCK LONGS
Stock price will be WELL over $5
"In a joint statement provided to New Jersey Business magazine by HMH spokesperson MaryJo Layton, the two organizations “have been pursuing an agreement to enhance the quality and value of diagnostic services to their patients and physicians."
Possible partnership with TTTO. A collaboration to speed up the results."Priority 1" will take approximately 2 days to get result, the rest will be more than 7 days.
"Hackensack Meridian Health, New Jersey's largest and most comprehensive health network, is pleased to announce that a rapid test for COVID-19 created by its labs at the Center for Discovery and Innovation (CDI) has been licensed to T2 Biosystems, a Massachusetts-based leader of in-vitro diagnostics."
"Under this agreement, T2 Biosystems is authorized to adapt the CDI-developed COVID-19 test to the T2 Biosystems platform, and market and distribute the test in places of need amid the expanding pandemic. The test will be capable of running on the T2Dx® Instrument, the same instrument which runs the FDA-cleared T2Bacteria® and T2Candida® Panels. The T2Bacteria and T2Candida Panels enable the rapid identification of sepsis-causing bacterial and fungal pathogens, providing results in three to five hours directly from whole blood, enabling clinicians to target therapy for patients with secondary bacterial or fungal infections associated with primary COVID-19 infections. "
https://njbmagazine.com/njb-news-now/800-hackensack-meridian-health-lab-workers-may-become-quest-employees/
https://www.usatoday.com/story/sports/college/columnist/dan-wolken/2020/07/21/nfl-college-football-increase-strain-covid-19-testing-capacity/5482338002/
https://www.prnewswire.com/news-releases/hackensack-meridian-healths-center-for-discovery-and-innovation-covid-19-test-licensed-to-t2-biosystems-for-widespread-deployment-301029255.html
CEO "Demand is not an issues, in fact, the demand is always there",added" Supply of Shipment is also no problem"
"Only issue is whether the Suppliers of product can keep up to meet the demand"
I think we can knock it out before it disappears,Trump said. That's what I want and if I had my choice between vaccines or therapeutics, give me therapeutics every time because I'd love to walk into a hospital and give everybody something and they start walking out in two days. That's what I'd like !!
https://www.newsweek.com/president-trump-says-give-me-therapeutics-over-covid-19-vaccine-1519852
Anyone catch the interview with DJT and Dr. Segal yesterday? DJT said at least 3 or 4 times, "we're making great progress with vaccines and therapeutics, especially therapeutics, given the choice between a vaccine and a therapeutic, I'll take a therapeutic any day, if the people go into the hospital, we give them the therapeutic, they get better and their out in a couple of days". Not an exact quote but very close...point being the Administration is definitely on our side, now let's get something going here, price is ridiculous!
Dear Stakeholder, Thank you for your interest in Seanergy Maritime Holdings. We would like to take this opportunity to kindly remind you of the upcoming video interview featuring an in-depth discussion between Stamatis Tsantanis, Chairman and CEO of Seanergy and Mr. Poe Fratt, Senior Research Analyst at Noble Capital Markets. The focus of this in-depth discussion will be on two main verticals: Firstly, Seanergy’s development, strategy, market positioning and competitive advantages. Secondly, it will examine the drybulk sector centering on the current Capesize market and critical issues surrounding the industry, its overall outlook and direction.
1. In order to watch the interview, please register ahead of time here:
https://www.seanergymaritime.com/en/news/newscasts/article-00F47A5027
2. At the time of the interview, on Thursday, July 23, 2020, 10 AM EDT, simply return to the same page to watch.
Regards,
The Capital Link team
+1-212-661-7566
Manipulating at its best .. Last few days we HIT the LOWER RESISTANCE @1.63-1.67 and BOUNCED BACK. The August news will keep us in this range or higher as the time grows closer so we might expect a better news and a share price.
This isnt a COVID boom or bust stock. This company has THE BEST SEPSIS test in the market. current test takes 3.5 DAYS. theirs takes 3.5 HOURS. It is being written about in top medical journals and will be a gold mine in the future. Sepsis kills more annually compared to cancer. look it up.
There was manipulated pre-market shares dumped(less than 80k shares) at lower than asking price ($1.79-1.80). Led to the 811k shares panic sell from small account after. Shares are running dry, most are HOLDING. Check out the new on sepsis testing success yesterday at 100% with result less than 3.5 hours while the existing testing is 84 hours.
https://12bajzvm4xtfmfqi20b5icjl-wpengine.netdna-ssl.com/wp-content/uploads/2020/05/Douka-ECCMID-2020.pdf
ATHX is going to get a substantial collaboration/funding deal from federal government any day. Longs hold strong Listen to every word the Athx management team has said so far and you see a biotech company that will rival AMGN in coming months to years !! Let's not forget Every biotech stock that can help in Covid 19 pandemic is up anywhere 100%-1000% ATHX will be next .. GOOD LUCK LONGS
Evaluation of T2MR in a Greek university intensive care unit
Evangelia Douka / Ioannis Papachatzakis / Charikleia Vrettou / Eleftheria Mizi / Efstathia Perivoliotis / Spiros Zakynthinos 12
FirstdepartmentofCriticalCareMedicine,UniversityofAthens,EvangelismosGeneralHospital,Athens,Greece, Microbiology 3
Department, Evangelismos General Hospital, Athens, Greece, na, Greece Evaggelismos General Hospital, Microbiology Department, Athi- Background: T2 Magnetic Resonance (T2MR) is a novel method of detecting ESKAPE pathogens in blood speciments. T2MR test is a fully automated procedure which amplifies microbial cell-associated DNA using a thermostable polymerase and tar- get-precific primers and detects signals by amplicon-induced agglomeration of superparamagnetic particles and T2 magnetic resonance. We aim at evaluating the performance of this method in an ICU population. Materials/methods: This is a prospective observational study that took place in a 35 bed university ICU were surveillance data report 40 % ESCAPE pathogens in BCs. Inclusion criteria were age >18 y.o.,and clinical suspicion of a new bloodstream infection. Patients who were unsalvageable were excluded. A sample for T2MR and a blood culture (BC) sample were collected simultaneously from all patients. The T2MR test was run according to the manufacturer’s guidelines and the blood cultures were processed according to the hospital standard procedures.
Results: 26 patients were included in the study. The results of the T2MR and BCs are presented in the Table. In 20 cases the results of T2MR were in concordance with the BCs. In the remaining 6 cases, the BCs were negative while the T2 MR detected one or more ESKAPE pathogens. There were no false negative results. Mean time to culture positivity was 84 hours while mean time to T2MR result was 3.5 hours. The negative predictive value of T2MR was 100%
Conclusions: T2MR detects more pathogens than BCs and provides a quicker detection time that could shorten the time to targeted therapy. The number of positive T2MR cases with negative BCs can be attributed to the high sensitivity of T2MR com- pared to the gold standard (BCs).
https://12bajzvm4xtfmfqi20b5icjl-wpengine.netdna-ssl.com/wp-content/uploads/2020/05/Douka-ECCMID-2020.pdf
T2 chart is looking right in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. T2 stock should rise over 135% in the next 2-3 months and over 85% which the price should be trading $3.30 -- $5.25 .. GOOD LUCK LONGS
Insiders need to get on board right now. Where are the Insider Hedge Fund Managers ??? Sabby Management LLC reportedly owns 9.94% of SHIP back in APRIL 2020. Now I'm no Hedge Fund manager but wouldn't it be worth it to heavily invest right now with Stamatis N Tsantanis Chairman/CEO, Seanergy Martime Holdings Corp. sticking his neck out with Thurdsay's interview !!!!
This is a confirmation of "POOL TESTING" FROM THE FDA FDA FDA, it is no longer a suggestion or "WE SHOULD DO" kind of discussion. The current administration and FDA are planning to test everyone to control the Virus Spread. Although, if 1 in 4 people get tested positive, all of them will have to re-test again. However, ""concern that combining samples may make it more difficult to detect positives, since pooling in the laboratory dilutes any viral material present in the samples,"
This also means, the vaccine will take some more time to perform trial, they won't cut corner on safety, and until gather more data from volunteers. TESTING WILL BE THE NEXT BIG THING UNTIL VACCINE IS DONE SAFELY(We are nowhere near this, and not many people are willing to be lab rat of the new Vaccine).
Now, on TTOO, the past 2 weeks, we have some serious organic gain, which meant, No impulsive pump and dump, just a gradual amount of shares being pumped in after the current testing revenue was upgraded earlier this week from 10-20B to 75-100B revenue.The amount of Shares floating around ran drier and drier.
WE DONT HAVE IMPULSIVE DAY LIKE JULY 1st. Roughly over 30m shares were dumped on July 1st(1 SINGLE DAY), that caused the Panic-selling from small-med traders til July 7th. Since then we have roughly 4m shares pumped in on July 7th, and gradually increased until NOW(2-7m shares added daily). A healthy sign from people who did their DD on TTOO, and see the current potential market on Covid-19 testing.
Let me remind you that:
-TTOO HAS REAL REVENUE ON SEPSIS ALONE
-TTOO HAS REAL PRODUCT and COVID-19 PANEL IS NOT THE ONLY PRODUCT THEY HAVE!
-TTOO REVENUE BEAT ALL ANALYSIS and on UPWARD TREND( THAT IS WITHOUT THE NEW COVID-19 PANEL SALE)
-TTOO HAS 36.5M CASH ON HAND
-TTOO TESTING IS THE BEST TESTING SYSTEM ON THE MARKET RIGHT NOW that give result in LESS THAN 2 HOURS.
-TTOO NEVER DID ANY RESERVE SPLIT like other Covid-19 related, because TTOO RESPECT US ENOUGH TO NOT DILUTE THEIR SHARES VALUE AKA YOU!
-TTOO CEO John Sperzel(NEW since JAN 9,2020) know how to bring TTOO testing panel to the market, he used to be CEMI CEO.
https://stockmarketdaily.co/2020/07/18/t2-biosystems-nasdaqttoo-target-raised-by-canaccord-genuity/
"T2 Biosystems stock has undergone multiple analysts rating changes in the recent past. T2 Biosystems stock Target Raised by Canaccord Genuity on 7/16/2020. In a note to investors, the firm issued a new target price of $4.00. The analysts previously had $3.00 target price. Canaccord Genuity’s price target would indicate a potential upside of 153.16% from the stock’s previous close."
A message for newbies etc. .. There are some 200 different types of cells in the human body and most of them can be used or prescribed by a doctor without special permission. Taking proper precautions a doctor can transplant blood from one individual to another in the form of a blood transfusion. Blood contains mostly “RBC's”, red blood cells. No need to get approval from the FDA or to go through years of expensive clinical trials. That's good news if you happen to be bleeding to death. Same goes for white blood cells or platelets. A doctor can prescribe bone marrow to be transplanted from one individual to another... or a cornea, or a lung, or a liver, or a heart, or a hand or even a face can be transplanted from one human to another with just a doctor's order and proper precautions.
But if a doctor orders the transplant of MSC's from one individal to another the FDA steps in. A doctor can't even reimplant a patient's own MSC's. Special permission is required -either an FDA authorized IND or an EUA, or a formal FDA approval following submission of a BLA. Same goes for MAPC's or CAR-T cells. It can be confusing and for anyone investing in this space I recommend learning more about the FDA's HCT/P regulations and concepts like “minimal manipulation” and “homologous use”. It's the law of the land. And not just this land.
The “new” NIH guideline essentially admonishes doctors and patients to obey the law. Sort of like advising, “don't drive your car through a red light”. It should go without saying, however cells can be confusing for patients... and even investors. The public sometimes needs reminding... because let's face it: it takes time and a lot of investor money to obey the FDA regs. And when many people are grasping desperately at something, anything that might help with Covid-19... well, it's a situation where quackery can easily flare up and flourish; quackery defined as the sale of unproven medical products intended to treat human illness... in exchange for lucre.
So the NIH guideline is no problem for companies like MESO, ATHX, or PSTI that spend millions to comply with the law. Nothing “scary”, no “conspiracy”. However. some doctors and clinics outright break the law and the guideline is directed especially at them. Others try to skirt the law. $VODG is a good example, shipping MSC's to the Cayman Islands in support of “medical tourism”, where $25K can buy an infusion of stem cells to treat hair loss or a sore elbow or whatever. These activities tarnish the industry, devalue the cells, and should be shunned by investors imo. There are more honorable ways to make money .. GOOD LUCK LONGS
Reuters reports Iran's Pres. Rouhani addressed his nation and said that 25 MILLION have been infected; and that 200,000 are in hospital. He projected 35 million cases and locked down the country. Besides politics, what kind of numbers are those? Apocalyptic it seems. SAD. If you figure a 2% mortality rate that could be 500,000 deal in their country. So the idiots debating masks here are just as stupid as the deniers that were in theocratic Iran.
https://in.reuters.com/article/health-coronavirus-iran-idINKBN24J092
This arrangement gives Nikon CeLL innovation full access to Lonza's:
Engineering expertise for facility design, construction, and commissioning Commercial Scale Quality and Operational Systems
Cell and Gene Therapy manufacturing technology platforms
Broad Sales and Marketing network and expertise
Cell and Gene Therapy Subject Matter experts"
Remember Nikon is Healios' largest investor:)
Announcement of obtaining a license for manufacturing regenerative medicine products by Nikon CeLL innovation Co., Ltd.
April 14, 2020"
https://www.nikon.com/news/2020/0414_01.htm
Not misleading read it again .. GOOD LUCK
Also BARDA is quiet, ATHX is super quiet, they gotta to be busy curing some very sick people, you know we are in a pandemic. BARDA must be preparing to launch a therapeutic that actually works to halt the death count of this horrible pandemic. Gil is working very methodically, taking every step ever so cautiously. Team of Stanford graduates that started this company along with Gil have everything on line to deliver a world class company that will rival the big pharmaceuticals in the very near future. GIL has NEVER sold a single share of this company in over 25 years, he is holding out for hundred dollar bills not interested in flipping pennies. Gil say something that will change the world for better, give us a CURE that we desperately seek. I for one am not interested in company that puts out a fluff PR and crashes and burns next day. Gil show me something with substance, show me a company that is going to be the next Amgen or REGN. I am not going to step over one hundred dollar to pick up pennies !!!!!
MULTISTEM is curative so let’s say ATHX prices the therapy at $30,000 per dosage which is much lower than the numbers put out by analysts = Billion plus in revenues overnight, so essentially Athx becomes a commercialized corporation overnight.So what exactly happens if ATHX is awarded BARDA contract for Covid 19 and future pandemic stockpiling? ATHX PPS will reach $10.00-$20.00 along with multiple halts after the collaboration/funding news PR hits the wires!
Part 2. BARDA contract will not only put spotlight on the MACOVIA trial for covid 19 but also highlight the pivotal Stroke trial in US and Japan.
Part 3. Will highlight ATHX Trauma trial that is funded by DOD!
Part 4. MULTISTEM is curative so let’s say ATHX prices the therapy at $30,000 per dosage which is much lower than the numbers put out by analysts = Billion plus in revenues overnight, so essentially Athx becomes a commercialized corporation overnight.
Part 5. Insiders/partner Healios bought over $10 million worth of shares and now we see filings coming out with BOD open market purchases!
Part 6. B Of A analyst puts the Blue Sky scenario PPS at $37.00. Let the short covering begin now !!
Whoever is selling right now is a s#$#ker. Do you think the COVID news gets better or worse over the weekend ?? The drum beat calling for more testing will only continue to get louder and the desperation of the medical community and government to silence it will only get stronger. If you are on the sideline when the next press release hits you will have to settle for scraps instead of hitting the trifecta. GOOD LUCK LONGS
Something bigger at play here at ATHX than meet the eye, according to Mellon college of science article “ After nearly 20 years, Robert Mays is on the brink of bringing a groundbreaking stem cell therapy to market – just in time to help those suffering from COVID-19” I have been saying for months to friends now that it is very possible due to the pandemic that is out of control, ATHX could get full blown approval from FDA approval due to overwhelming efficacy seen in the open label first cohort of MACOVIA trial along with BARDA collaboration/funding and I think we are days away from it all coming to fruition. Long and strong, big believer in Gil & company !
ATHX HHS.GOV This agreement with Regeneron is the 1st of a number of Operation Warp Speed awards to support potential therapeutics all the way through to manufacturing, allowing faster distribution if trials are successful,” said HHS Secretary Alex Azar. “More good news about COVID-19 therapeutics is constantly emerging, and President Trump’s commitment to supporting lifesaving therapeutics will help deliver these products to American patients without a day’s delay.”
MACOVIA 60 data in hand, federal government is desperate need of MULTISTEM. We have to stop the death count. Upside $20.00, blue sky $37.00 downside .50 cents. Shorts !
Wrong post